Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Respiratory

PUBLISHER: Persistence Market Research | PRODUCT CODE: 1446751

Cover Image

PUBLISHER: Persistence Market Research | PRODUCT CODE: 1446751

Cough Suppressant Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2030

PUBLISHED:
PAGES: 179 Pages
DELIVERY TIME: 2-5 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4900
PDF & Excel (Multi User License)
USD 6400
PDF & Excel (Corporate User License)
USD 7400

Add to Cart

Description

Table of Contents

Persistence Market Research has recently published an extensive report on the global Cough Suppressant Market. The significant growth observed in this market underscores the increasing demand for effective cough relief medications, driven by factors such as the prevalence of respiratory infections, allergic reactions, and environmental pollutants leading to cough symptoms. The report highlights the essential role of cough suppressants in providing symptomatic relief from cough and related respiratory discomfort.

The Global Cough Suppressant Market is forecast to expand at a CAGR of 6.4% and thereby increase from a value of US$ 25,402.4 million in 2023 to US$ 39,216.3 million by the end of 2030.

Key Insights:

  • Cough Suppressant Market Size (2023E): US$ 25,402.4 Million
  • Projected Market Value (2030F): US$ 39,216.3 Million
  • Global Market Growth Rate (CAGR 2023 to 2030): 6.4%
  • Historical Market Growth Rate (CAGR 2018 to 2022): 5.2%

Cough Suppressant Market - Report Scope:

The Cough Suppressant Market report offers an in-depth analysis of market dynamics, focusing on historical trends and future projections. Cough suppressants, also known as antitussives, are medications that alleviate cough symptoms by suppressing the cough reflex in the brainstem. The report delves into the nuances of the cough suppressant market, examining factors driving market growth, key market players, and emerging trends shaping the industry landscape.

Market Growth Drivers for Cough Suppressant Market:

The increasing prevalence of respiratory conditions, such as the common cold, influenza, bronchitis, and asthma, drives the demand for cough suppressants as over-the-counter (OTC) and prescription medications for symptom management. Cough suppressants provide relief from dry, non-productive coughs by inhibiting the cough reflex and reducing cough frequency and severity, thereby improving patient comfort and quality of life.

Furthermore, changing lifestyles, environmental pollution, and exposure to respiratory irritants contribute to the rising incidence of chronic cough conditions, such as postnasal drip syndrome, gastroesophageal reflux disease (GERD), and chronic obstructive pulmonary disease (COPD), necessitating long-term use of cough suppressants for symptom control and disease management. Moreover, advancements in formulation technologies, such as extended-release formulations, combination therapies, and flavored syrups, enhance patient compliance and convenience, driving market adoption and acceptance.

Market Restraints:

Despite the favorable market outlook, the cough suppressant market faces challenges related to safety concerns, regulatory compliance, and competition from alternative therapies. Some cough suppressants, particularly opioid-based formulations, may carry risks of respiratory depression, sedation, and addiction, leading to regulatory scrutiny, label warnings, and prescribing restrictions, which may impact market growth and prescription patterns.

Moreover, the availability of non-pharmacological cough remedies, such as honey, herbal teas, steam inhalation, and saline gargles, poses competition to cough suppressant medications, particularly among consumers seeking natural or homeopathic remedies for cough relief. Additionally, regulatory changes, patent expirations, and generic competition may exert pricing pressures on branded cough suppressants, affecting market revenues and profit margins for pharmaceutical companies.

Market Opportunities:

Amidst the challenges lie opportunities for innovation and market expansion within the cough suppressant market. Leveraging advancements in drug delivery systems, nanotechnology, and pharmacogenomics can lead to the development of novel cough suppressant formulations with improved efficacy, safety, and patient outcomes. Innovations such as biodegradable microparticles, mucoadhesive patches, and targeted drug delivery systems can enhance drug bioavailability, reduce systemic side effects, and optimize therapeutic responses.

Furthermore, expanding indications for cough suppressants beyond respiratory conditions to non-respiratory disorders, such as neuropathic cough, chronic pain syndromes, and neurogenic dysphagia, can unlock new growth opportunities and market potential. Collaborations between pharmaceutical companies, academic research institutions, and healthcare providers can facilitate drug discovery, clinical development, and market access for innovative cough suppressant therapies tailored to specific patient populations and clinical needs.

Key Questions Answered in Report::

  • What is the Forecast CAGR of the Cough Suppressant Market in 2030?
  • What is the Global Market Size of Cough Suppressants as of the End of 2023?
  • Which Region Dominated the Cough Suppressant Market in 2023?
  • Who are the Key Players in the Global Cough Suppressant Market?
  • Which Cough Suppressant Segments Hold the Largest Opportunities for Market Integration?

Competitive Intelligence and Business Strategy:

In navigating the competitive landscape, companies in the Cough Suppressant Market must leverage competitive intelligence and strategic business initiatives to differentiate themselves and capitalize on emerging opportunities. Understanding market dynamics, customer preferences, and competitor strategies is essential for informed decision-making and market positioning.

Furthermore, investing in research and development, clinical trials, and regulatory affairs can help companies drive innovation, secure intellectual property rights, and obtain regulatory approvals for new cough suppressant formulations and indications. By focusing on product differentiation, branding, and marketing strategies, companies can enhance market penetration, gain market share, and sustain competitive advantage in the dynamic Cough Suppressant Market.

Key Companies Profiled:

  • Abbott Laboratories
  • Acella Pharmaceuticals, LLC
  • GlaxoSmithKline Plc
  • Johnson & Johnson services Inc.
  • Merck KGaA
  • Novartis International AG
  • Pfizer Inc.
  • Procter & Gamble

Cough Suppressant Market Research Segmentation:

Market segmentation based on drug class, by dosage form, by distribution channel, and region provides valuable insights into key market segments and regional dynamics, enabling companies to tailor their offerings to specific customer needs and preferences. By understanding the unique requirements of different customer segments and geographic markets, companies can develop targeted strategies to address market demands effectively, thereby gaining a competitive edge and driving growth in the Cough Suppressant Market.

By Type:

  • Acute Cough
  • Chronic Cough

By Drugs:

  • Dextromethorphan
  • Codeine
  • Butramirate
  • Bennzonatate
  • Others

By Form:

  • Solid
  • Liquid
  • Spray

By Distribution Channel:

  • Hospitals
  • Retail Pharmacies
  • Drug Stores
  • Online Pharmacies

By Region:

  • North America
  • Europe
  • East Asia
  • South Asia & Oceania
  • Latin America
  • Middle East & Africa
Show more
Product Code: PMRREP33790

Table of Contents

1. Executive Summary

  • 1.1. Global Cough Suppressant Market Snapshot, 2023 and 2030
  • 1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Type Lifecycle Analysis
  • 2.4. Cough Suppressant Market: Value Chain
    • 2.4.1. List of Raw Material Supplier
    • 2.4.2. List of Manufacturers
    • 2.4.3. List of Distributors
    • 2.4.4. List of Applications
    • 2.4.5. Profitability Analysis
  • 2.5. Porter Five Force's Analysis
  • 2.6. Geopolitical Tensions: Market Impact
  • 2.7. Macro-Economic Factors
    • 2.7.1. Global Sectorial Outlook
    • 2.7.2. Global GDP Growth Outlook
    • 2.7.3. Global Parent Market Overview
  • 2.8. Forecast Factors - Relevance and Impact
  • 2.9. Regulatory and Technology Landscape

3. Global Cough Suppressant Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 3.1. Key Highlights
    • 3.1.1. Market Volume (Units) Projections
    • 3.1.2. Market Size and Y-o-Y Growth
    • 3.1.3. Absolute $ Opportunity
  • 3.2. Market Size (US$ Mn) Analysis and Forecast
    • 3.2.1. Historical Market Size Analysis, 2013-2016
    • 3.2.2. Current Market Size Forecast, 2018-2026
  • 3.3. Global Cough Suppressant Market Outlook: Type
    • 3.3.1. Introduction / Key Findings
    • 3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Type, 2018 - 2022
    • 3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2023 - 2030
      • 3.3.3.1. Acute Cough
      • 3.3.3.2. Chronic Cough
  • 3.4. Market Attractiveness Analysis: Type
  • 3.5. Global Cough Suppressant Market Outlook: Drugs
    • 3.5.1. Introduction / Key Findings
    • 3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Drugs, 2018 - 2022
    • 3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Drugs, 2023 - 2030
      • 3.5.3.1. Dextromethorphan
      • 3.5.3.2. Codeine
      • 3.5.3.3. Butramirate
      • 3.5.3.4. Bennzonatate
      • 3.5.3.5. Others
  • 3.6. Market Attractiveness Analysis: Drugs
  • 3.7. Global Cough Suppressant Market Outlook: Form
    • 3.7.1. Introduction / Key Findings
    • 3.7.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Form, 2018 - 2022
    • 3.7.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Form, 2023 - 2030
      • 3.7.3.1. Solid
      • 3.7.3.2. Liquid
      • 3.7.3.3. Spray
  • 3.8. Market Attractiveness Analysis: Form
  • 3.9. Global Cough Suppressant Market Outlook: Distribution Channel
    • 3.9.1. Introduction / Key Findings
    • 3.9.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Distribution Channel, 2018 - 2022
    • 3.9.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
      • 3.9.3.1. Hospitals
      • 3.9.3.2. Retail pharmacies
      • 3.9.3.3. Drug stores
      • 3.9.3.4. Online Pharmacies
  • 3.10. Market Attractiveness Analysis: Distribution Channel

4. Global Cough Suppressant Market Outlook: Region

  • 4.1. Key Highlights
  • 4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
  • 4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
    • 4.3.1. North America
    • 4.3.2. Europe
    • 4.3.3. East Asia
    • 4.3.4. South Asia & Pacific
    • 4.3.5. Latin America
    • 4.3.6. Middle East & Africa (MEA)
  • 4.4. Market Attractiveness Analysis: Region

5. North America Cough Suppressant Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 5.1. Key Highlights
  • 5.2. Pricing Analysis
  • 5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 5.3.1. By Country
    • 5.3.2. By Type
    • 5.3.3. By Drugs
    • 5.3.4. By Form
    • 5.3.5. By Distribution Channel
  • 5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 5.4.1. U.S.
    • 5.4.2. Canada
  • 5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2023 - 2030
    • 5.5.1. Acute Cough
    • 5.5.2. Chronic Cough
  • 5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Drugs, 2023 - 2030
    • 5.6.1. Dextromethorphan
    • 5.6.2. Codeine
    • 5.6.3. Butramirate
    • 5.6.4. Bennzonatate
    • 5.6.5. Others
  • 5.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Form, 2023 - 2030
    • 5.7.1. Solid
    • 5.7.2. Liquid
    • 5.7.3. Spray
  • 5.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
    • 5.8.1. Hospitals
    • 5.8.2. Retail pharmacies
    • 5.8.3. Drug stores
    • 5.8.4. Online Pharmacies
  • 5.9. Market Attractiveness Analysis

6. Europe Cough Suppressant Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 6.1. Key Highlights
  • 6.2. Pricing Analysis
  • 6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 6.3.1. By Country
    • 6.3.2. By Type
    • 6.3.3. By Drugs
    • 6.3.4. By Form
    • 6.3.5. By Distribution Channel
  • 6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 6.4.1. Germany
    • 6.4.2. France
    • 6.4.3. U.K.
    • 6.4.4. Italy
    • 6.4.5. Spain
    • 6.4.6. Russia
    • 6.4.7. Turkeys
    • 6.4.8. Rest of Europe
  • 6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2023 - 2030
    • 6.5.1. Acute Cough
    • 6.5.2. Chronic Cough
  • 6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Drugs, 2023 - 2030
    • 6.6.1. Dextromethorphan
    • 6.6.2. Codeine
    • 6.6.3. Butramirate
    • 6.6.4. Bennzonatate
    • 6.6.5. Others
  • 6.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Form, 2023 - 2030
    • 6.7.1. Solid
    • 6.7.2. Liquid
    • 6.7.3. Spray
  • 6.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
    • 6.8.1. Hospitals
    • 6.8.2. Retail pharmacies
    • 6.8.3. Drug stores
    • 6.8.4. Online Pharmacies
  • 6.9. Market Attractiveness Analysis

7. East Asia Cough Suppressant Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 7.1. Key Highlights
  • 7.2. Pricing Analysis
  • 7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 7.3.1. By Country
    • 7.3.2. By Type
    • 7.3.3. By Drugs
    • 7.3.4. By Form
    • 7.3.5. By Distribution Channel
  • 7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 7.4.1. China
    • 7.4.2. Japan
    • 7.4.3. South Korea
  • 7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2023 - 2030
    • 7.5.1. Acute Cough
    • 7.5.2. Chronic Cough
  • 7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Drugs, 2023 - 2030
    • 7.6.1. Dextromethorphan
    • 7.6.2. Codeine
    • 7.6.3. Butramirate
    • 7.6.4. Bennzonatate
    • 7.6.5. Others
  • 7.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Form, 2023 - 2030
    • 7.7.1. Solid
    • 7.7.2. Liquid
    • 7.7.3. Spray
  • 7.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
    • 7.8.1. Hospitals
    • 7.8.2. Retail pharmacies
    • 7.8.3. Drug stores
    • 7.8.4. Online Pharmacies
  • 7.9. Market Attractiveness Analysis

8. South Asia & Pacific Cough Suppressant Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 8.1. Key Highlights
  • 8.2. Pricing Analysis
  • 8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 8.3.1. By Country
    • 8.3.2. By Type
    • 8.3.3. By Drugs
    • 8.3.4. By Form
    • 8.3.5. By Distribution Channel
  • 8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 8.4.1. India
    • 8.4.2. Southeast Asia
    • 8.4.3. ANZ
    • 8.4.4. Rest of South Asia & Pacific
  • 8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2023 - 2030
    • 8.5.1. Acute Cough
    • 8.5.2. Chronic Cough
  • 8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Drugs, 2023 - 2030
    • 8.6.1. Dextromethorphan
    • 8.6.2. Codeine
    • 8.6.3. Butramirate
    • 8.6.4. Bennzonatate
    • 8.6.5. Others
  • 8.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Form, 2023 - 2030
    • 8.7.1. Solid
    • 8.7.2. Liquid
    • 8.7.3. Spray
  • 8.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
    • 8.8.1. Hospitals
    • 8.8.2. Retail pharmacies
    • 8.8.3. Drug stores
    • 8.8.4. Online Pharmacies
  • 8.9. Market Attractiveness Analysis

9. Latin America Cough Suppressant Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 9.1. Key Highlights
  • 9.2. Pricing Analysis
  • 9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 9.3.1. By Country
    • 9.3.2. By Type
    • 9.3.3. By Drugs
    • 9.3.4. By Form
    • 9.3.5. By Distribution Channel
  • 9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America
  • 9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2023 - 2030
    • 9.5.1. Acute Cough
    • 9.5.2. Chronic Cough
  • 9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Drugs, 2023 - 2030
    • 9.6.1. Dextromethorphan
    • 9.6.2. Codeine
    • 9.6.3. Butramirate
    • 9.6.4. Bennzonatate
    • 9.6.5. Others
  • 9.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Form, 2023 - 2030
    • 9.7.1. Solid
    • 9.7.2. Liquid
    • 9.7.3. Spray
  • 9.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
    • 9.8.1. Hospitals
    • 9.8.2. Retail pharmacies
    • 9.8.3. Drug stores
    • 9.8.4. Online Pharmacies
  • 9.9. Market Attractiveness Analysis

10. Middle East & Africa Cough Suppressant Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 10.1. Key Highlights
  • 10.2. Pricing Analysis
  • 10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 10.3.1. By Country
    • 10.3.2. By Type
    • 10.3.3. By Drugs
    • 10.3.4. By Form
    • 10.3.5. By Distribution Channel
  • 10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 10.4.1. GCC
    • 10.4.2. Egypt
    • 10.4.3. South Africa
    • 10.4.4. Northern Africa
    • 10.4.5. Rest of Middle East & Africa
  • 10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2023 - 2030
    • 10.5.1. Acute Cough
    • 10.5.2. Chronic Cough
  • 10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Drugs, 2023 - 2030
    • 10.6.1. Dextromethorphan
    • 10.6.2. Codeine
    • 10.6.3. Butramirate
    • 10.6.4. Online Pharmacies
  • 10.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Form, 2023 - 2030
    • 10.7.1. Solid
    • 10.7.2. Liquid
    • 10.7.3. Spray
  • 10.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
    • 10.8.1. Hospitals
    • 10.8.2. Retail pharmacies
    • 10.8.3. Drug stores
    • 10.8.4. Online Pharmacies
  • 10.9. Market Attractiveness Analysis

11. Competition Landscape

  • 11.1. Market Share Analysis, 2022
  • 11.2. Market Structure
    • 11.2.1. Competition Intensity Mapping By Market
    • 11.2.2. Competition Chronic Cough
    • 11.2.3. Apparent Product Capacity
  • 11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 11.3.1. Abbott Laboratories
      • 11.3.1.1. Overview
      • 11.3.1.2. Segments and Product
      • 11.3.1.3. Key Financials
      • 11.3.1.4. Market Developments
      • 11.3.1.5. Market Strategy
    • 11.3.2. Acella Pharmaceuticals, LLC
      • 11.3.2.1. Overview
      • 11.3.2.2. Segments and Product
      • 11.3.2.3. Key Financials
      • 11.3.2.4. Market Developments
      • 11.3.2.5. Market Strategy
    • 11.3.3. GlaxoSmithKline Plc
      • 11.3.3.1. Overview
      • 11.3.3.2. Segments and Product
      • 11.3.3.3. Key Financials
      • 11.3.3.4. Market Developments
      • 11.3.3.5. Market Strategy
    • 11.3.4. Johnson & Johnson services Inc.
      • 11.3.4.1. Overview
      • 11.3.4.2. Segments and Product
      • 11.3.4.3. Key Financials
      • 11.3.4.4. Market Developments
      • 11.3.4.5. Market Strategy
    • 11.3.5. Merck KGaA
      • 11.3.5.1. Overview
      • 11.3.5.2. Segments and Product
      • 11.3.5.3. Key Financials
      • 11.3.5.4. Market Developments
      • 11.3.5.5. Market Strategy
    • 11.3.6. Novartis International AG
      • 11.3.6.1. Overview
      • 11.3.6.2. Segments and Product
      • 11.3.6.3. Key Financials
      • 11.3.6.4. Market Developments
      • 11.3.6.5. Market Strategy
    • 11.3.7. Pfizer Inc.
      • 11.3.7.1. Overview
      • 11.3.7.2. Segments and Product
      • 11.3.7.3. Key Financials
      • 11.3.7.4. Market Developments
      • 11.3.7.5. Market Strategy
    • 11.3.8. Procter & Gamble
      • 11.3.8.1. Overview
      • 11.3.8.2. Segments and Product
      • 11.3.8.3. Key Financials
      • 11.3.8.4. Market Developments
      • 11.3.8.5. Market Strategy
    • 11.3.9. Reckitt Benckiser Group Plc.
      • 11.3.9.1. Overview
      • 11.3.9.2. Segments and Product
      • 11.3.9.3. Key Financials
      • 11.3.9.4. Market Developments
      • 11.3.9.5. Market Strategy
    • 11.3.10. Sanofi
      • 11.3.10.1. Overview
      • 11.3.10.2. Segments and Product
      • 11.3.10.3. Key Financials
      • 11.3.10.4. Market Developments
      • 11.3.10.5. Market Strategy
    • 11.3.11. Perrigo Company Plc
      • 11.3.11.1. Overview
      • 11.3.11.2. Segments and Product
      • 11.3.11.3. Key Financials
      • 11.3.11.4. Market Developments
      • 11.3.11.5. Market Strategy

12. Appendix

  • 12.1. Research Methodology
  • 12.2. Research Assumptions
  • 12.3. Acronyms and Abbreviations
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!